Don’t Let Your Pharma Program Fall Behind – Optimize It Now

How do you know if your program needs to be optimized? Here are several questions to ask yourself:
-
- Does your program seem misaligned with the overall brand ecosystem?
- Does your program face consistent escalations?
- Is your sales force focused more on the HUB process and pull-through than selling?
- Does your program metrics data seem “off”?
- Do seemingly small process changes cause setbacks?
- Does your team seem busy but unproductive?
- Do your vendor contacts seem to be burned out?
- Are you hearing conflicting information from your vendor and HCPs about cycle time or specific services?
- Do you have low HCP and/or patient satisfaction ratings?
- Is your program staff consistently working overtime?
If you answered “yes” to one or more of the questions above, program optimization could make sense.
Every program has its story, just like a resolution. Optimizing is about moving forward to a new and better chapter. Archbow can assist with your program optimization strategy. We are highly experienced in designing proactive optimization approaches, identifying room for improvement, analyzing vendor performance, and modernizing technology in existing programs. Contact us today to get started.
For additional insights on this topic, you may also enjoy the following:
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.
Share in
Recent Posts
The Rise of Digital Health and Technology Integration in the Pharmaceutical Industry
In 2025, digital health is no longer a future consideration—it is a present imperative for key industry players in the pharmaceutical services sector, including manufacturers, specialty pharmacies, payers, and providers
Direct-to-Consumer (DTC) Changes Under the New Executive Order: What You Need to Know
As the US administration urges leading pharmaceutical manufacturers to implement MFN prescription drug pricing solutions, innovative approaches like DTC distribution for prescription medications are gaining increased attention.
Navigating the Complex World of Pharmaceutical Returns Processing
Efficiently managing product returns is a critical lever for controlling costs, minimizing operational inefficiencies, and reducing end-to-end complexity.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|